FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dave Hoon

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Anatomy

Co-author Network

Publications

TOP 3
Rizwan Haq; Elena B Hawryluk; Dave S B Hoon; Göran B Jönsson; Robert Langer; Kevin T Love; Kevin McHenry; Donald L Morton; Dale Porter; Jun S Song; Thanh-Nga Tran; Jennifer A Wargo; Satoru Yokoyama; Daniel G Anderson; Lyn McDivitt Duncan; Dennie Tompers Frederick; Levi A Garraway; David E Fisher
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
Anat Klein; Tsipi Meshel; Clara Nahmias; Metsada Pasmanik-Chor; Orit Sagi-Assif; Pierre-Olivier Couraud; Neta Erez; Dave S B Hoon; Sivan Izraely; Isaac P Witz
The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
Toshiaki Shinojima; Qiang Yu; Dave S B Hoon; Sharon K Huang; Michelle Li; Edison T Liu; Ryuichi Mizuno; Laurent Lessard
Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dave Hoon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Rizwan Haq; Elena B Hawryluk; Dave S B Hoon; Göran B Jönsson; Robert Langer; Kevin T Love; Kevin McHenry; Donald L Morton; Dale Porter; Jun S Song; Thanh-Nga Tran; Jennifer A Wargo; Satoru Yokoyama; Daniel G Anderson; Lyn McDivitt Duncan; Dennie Tompers Frederick; Levi A Garraway; David E Fisher
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
Proceedings of the National Academy of Sciences of the United States of America 2013;110(11):4321-6.
2012: Anat Klein; Tsipi Meshel; Clara Nahmias; Metsada Pasmanik-Chor; Orit Sagi-Assif; Pierre-Olivier Couraud; Neta Erez; Dave S B Hoon; Sivan Izraely; Isaac P Witz
The metastatic microenvironment: Brain-derived soluble factors alter the malignant phenotype of cutaneous and brain-metastasizing melanoma cells.
International journal of cancer. Journal international du cancer 2012;131(11):2509-18.
2012: Toshiaki Shinojima; Qiang Yu; Dave S B Hoon; Sharon K Huang; Michelle Li; Edison T Liu; Ryuichi Mizuno; Laurent Lessard
Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.
Epigenetics : official journal of the DNA Methylation Society 2012;7(11):1279-89.
2012: Sojun Hoshimoto; Christine Kuo; Donald L Morton; Tatsushi Shingai; He-Jing Wang; Kelly Chong; David Elashoff; Robert M Elashoff; Mark B Faries; Dave S B Hoon
Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(31):3819-26.
2012: Diego M Marzese; Javier I Orozco; Kelly K Chong; Francisco E Gago; Dave S B Hoon; OM Tello; Laura M Vargas-Roig; María Roqué
DNA methylation index and methylation profile of invasive ductal breast tumors.
The Journal of molecular diagnostics : JMD 2012;14(6):613-22.
2012: Stanley P L Leong; Martin C Mihm; George F Murphy; Vernon K Sondak; Jonathan S Zager; Sanjiv S Agarwala; Valerie Guild; Axel Hauschild; Dave S B Hoon; Mohammed Kashani-Sabet; John M Kirkwood
Progression of cutaneous melanoma: implications for treatment.
Clinical & experimental metastasis 2012;29(7):775-96.
2012: Sivan Izraely; Anat Klein; Tsipi Meshel; Clara Nahmias; Metsada Pasmanik-Chor; Orit Sagi-Assif; Galia Tsarfaty; Eugene Ateh; Joseph L Bryant; Pierre-Olivier Couraud; Dave S B Hoon; Isaac P Witz
The metastatic microenvironment: brain-residing melanoma metastasis and dormant micrometastasis.
International journal of cancer. Journal international du cancer 2012;131(5):1071-82.
2012: Anneke Q van Hoesel; Johanna G H van Nes; Esther M de Kruijf; David A Elashoff; Armando E Giuliano; Peter Kuppen; GJ Liefers; Hein Putter; Yusuke Sato; Jaime M Shamonki; Roderick R Turner; Cornelis J H van de Velde; Dave S B Hoon
Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study.
Breast cancer research and treatment 2012;134(3):1103-14.
2012: Naofumi Kagara; Christine Kuo; Hideyuki Okano; Myung Shin Sim; Kelly Chong; David Elashoff; Armando E Giuliano; Kelly T Huynh; Dave S B Hoon
Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
The American journal of pathology 2012;181(1):257-67.
2012: Sojun Hoshimoto; Sharon K Huang; Christine T Kuo; Michelle W Li; Donald L Morton; Myung-Shin Sim; Yoshiki Takei; Teh-Ling Takeshima; Kelly K Chong; Dave S B Hoon
AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
The Journal of investigative dermatology 2012;132(6):1689-97.
2012: Jiehui Deng; Robert A Figlin; Stephen Forman; Andreas Herrmann; Dave S B Hoon; Richard Jove; Maciej Kujawski; Heehyoung Lee; Jie Liu; Yong Liu; Sumanta K Pal; Saul J Priceman; Andrew Raubitschek; Shudan Shen; Chunyan Zhang; Wang Zhang; Hua Yu
S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.
Cancer cell 2012;21(5):642-54.
2012: Heehyoung Lee; Arthur D Riggs; Zhenghe Wang; Hong Xin; Chunmei Yang; Stephen J Forman; Andreas Herrmann; Dave S B Hoon; Richard Jove; Peng Zhang; Hua Yu
Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation.
Proceedings of the National Academy of Sciences of the United States of America 2012;109(20):7765-9.
2012: Sojun Hoshimoto; MC Kelley; Christine Kuo; Jeffrey E Lee; Donald L Morton; Nicola Mozzillo; Tatsushi Shingai; John F Thompson; He-Jing Wang; Robert Elashoff; Mark B Faries; Dave S B Hoon
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.
Annals of surgery 2012;255(2):357-62.
2012: Anneke Q van Hoesel; Johanna G H van Nes; Esther M de Kruijf; Armando E Giuliano; Peter Kuppen; Hein Putter; Cornelis J H van de Velde; Dave S B Hoon
Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer.
Breast cancer research and treatment 2012;131(3):859-69.
2011: Makoto Nagahara; Tsuyoshi Nakagawa; Naohiro Nishida; Takanobu Sato; Kenichi Sugihara; Fumiaki Tanaka; Dave S B Hoon; Shinya Ishimaru; Masaaki Iwatsuki; Koshi Mimori; Masaki Mori
Kinesin 18A expression: clinical relevance to colorectal cancer progression.
International journal of cancer. Journal international du cancer 2011;129(11):2543-52.
2011: Ryo Tanaka; Kazuo Koyanagi; Christine Kuo; Norihiko Narita; Dave S B Hoon
Prognostic molecular biomarkers for cutaneous malignant melanoma.
Journal of surgical oncology 2011;104(4):438-46.
2011: Tetsunori Yoshimura; Christine Kuo; Makoto Nagahara; Patrick Soon-Shiong; Roderick R Turner; Dave S B Hoon
Lymphovascular invasion of colorectal cancer is correlated to SPARC expression in the tumor stromal microenvironment.
Epigenetics : official journal of the DNA Methylation Society 2011;6(8):1001-11.
2011: Sheldon Feldman; William Gillanders; Mark Gittleman; Armando E Giuliano; Linda K Han; Robert Hermann; Dave S B Hoon; Savitri Krishnamurthy; Edward A Levine; Funda Meric-Bernstam; Christian J Streck; Pat W Whitworth; Peter R Young; Peter D Beitsch; Susan Boolbol
A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes.
Cancer 2011;117(12):2599-607.
2011: Heidi Schwarzenbach; Dave S B Hoon; Klaus Pantel
Cell-free nucleic acids as biomarkers in cancer patients.
Nature reviews. Cancer 2011;11(6):426-37.
2011: Dave S B Hoon; Robert Ferris; Ryo Tanaka; Kelly K Chong; Catherine Alix-Panabières; Klaus Pantel
Molecular mechanisms of metastasis.
Journal of surgical oncology 2011;103(6):508-17.
2011: Tung Nguyen; Christine Kuo; Michael B Nicholl; Myung-Shin Sim; Roderick R Turner; Donald L Morton; Dave S B Hoon
Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
Epigenetics : official journal of the DNA Methylation Society 2011;6(3):388-94.
2011: Eiji Sunami; Michiel de Maat; Anna Vu; Roderick R Turner; Dave S B Hoon
LINE-1 hypomethylation during primary colon cancer progression.
PloS one 2011;6(4):e18884.
2011: Michael B Nicholl; David Elashoff; Hiroya Takeuchi; Donald L Morton; Dave S B Hoon
Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients.
Annals of surgery 2011;253(1):116-22.
2011: Sota Asaga; Christine Kuo; Tung Nguyen; Marilou Terpenning; Armando E Giuliano; Dave S B Hoon
Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer.
Clinical chemistry 2011;57(1):84-91.
2010: Takaaki Arigami; Norihiko Narita; Ryuichi Mizuno; Linhda Nguyen; Xing Ye; Alice Chung; Armando E Giuliano; Dave S B Hoon
B7-h3 ligand expression by primary breast cancer and associated with regional nodal metastasis.
Annals of surgery 2010;252(6):1044-51.
2010: Michiel F G de Maat; Norihiko Narita; Anne Benard; Tetsunori Yoshimura; Christine Kuo; Rob A E M Tollenaar; Noel F C C de Miranda; Roderick R Turner; Cornelis J H van de Velde; Hans Morreau; Dave S B Hoon
Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma.
The American journal of pathology 2010;177(5):2347-56.
2010: Michiel F G de Maat; Cornelis J H van de Velde; Anne Benard; Hein Putter; Hans Morreau; J Han J M van Krieken; Elma Meershoek Klein-Kranenbarg; Eelco J de Graaf; Rob A E M Tollenaar; Dave S B Hoon
Identification of a quantitative MINT locus methylation profile predicting local regional recurrence of rectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(10):2811-8.
2010: Sivan Izraely; Anat Klein; Orit Sagi-Assif; Tsipi Meshel; Galia Tsarfaty; Dave S B Hoon; Isaac P Witz
Chemokine-chemokine receptor axes in melanoma brain metastasis.
Immunology letters 2010;130(1-2):107-14.
2010: Kazuo Koyanagi; Steven J O'Day; Peter D Boasberg; Michael B Atkins; He-Jing Wang; Rene Gonzalez; Karl Lewis; John A Thompson; Clay M Anderson; Jose Lutzky; Thomas T Amatruda; Evan M Hersh; Jon Richards; Jeffrey S Weber; Dave S B Hoon
Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(8):2402-8.
2010: Yasufumi Goto; Takaaki Arigami; Rajmohan Murali; Richard A Scolyer; Atsushi Tanemura; Minoru Takata; Roderick R Turner; Linhda Nguyen; Tung Nguyen; Donald L Morton; Soldano Ferone; Dave S B Hoon
High molecular weight-melanoma-associated antigen as a biomarker of desmoplastic melanoma.
Pigment cell & melanoma research 2010;23(1):137-40.
2010: Yasufumi Goto; Kazuo Koyanagi; Norihiko Narita; Yutaka Kawakami; Minoru Takata; Aya Uchiyama; Linhda Nguyen; Tung Nguyen; Xing Ye; Donald L Morton; Dave S B Hoon
Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma.
The Journal of investigative dermatology 2010;130(1):221-9.
2009: Yusuke Sato; Yasufumi Goto; Norihiko Narita; Dave S B Hoon
Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment.
Cancer microenvironment : official journal of the International Cancer Microenvironment Society 2009;2 Suppl 1():205-14.
2009: N Narita; A Tanemura; R Murali; R A Scolyer; S Huang; Takaaki Arigami; S Yanagita; K K Chong; J F Thompson; Donald L Morton; Dave S B Hoon
Functional RET G691S polymorphism in cutaneous malignant melanoma.
Oncogene 2009;28(34):3058-68.
2009: Minoru Kitago; Steve Martinez; Takeshi Nakamura; Myung-Shin Sim; Dave S B Hoon
Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(9):2988-94.
2009: Minoru Kitago; Kazuo Koyanagi; Takeshi Nakamura; Yasufumi Goto; Mark Faries; Steven J O'Day; Donald L Morton; Soldano Ferrone; Dave S B Hoon
mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclonal antibody beads.
Clinical chemistry 2009;55(4):757-64.
2009: Atsushi Tanemura; Alicia M Terando; Myung-Shin Sim; Anneke Q van Hoesel; Michiel F G de Maat; Donald L Morton; Dave S B Hoon
CpG island methylator phenotype predicts progression of malignant melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(5):1801-7.
2009: Eiji Sunami; Masaru Shinozaki; Celestia S Higano; Robert Wollman; Tanya B Dorff; Steven J Tucker; Steve Martinez; Ryuich Mizuno; Frederick R Singer; Dave S B Hoon
Multimarker circulating DNA assay for assessing blood of prostate cancer patients.
Clinical chemistry 2009;55(3):559-67.
2009: Takeshi Nakamura; Eiji Sunami; Tuny Nguyen; Dave S B Hoon
Analysis of loss of heterozygosity in circulating DNA.
Methods in molecular biology (Clifton, N.J.) 2009;520():221-9.
2009: Sharon K Huang; Marlene M Darfler; Michael B Nicholl; Jin-Sam You; Kerry G Bemis; Tony J Tegeler; Mu Wang; Jean-Pierre Wery; Kelly K Chong; Linhda Nguyen; Richard A Scolyer; Dave S B Hoon
LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis.
PloS one 2009;4(2):e4430.
2009: Eiji Sunami; Anh-Thu Vu; Sandy L Nguyen; Dave S B Hoon
Analysis of methylated circulating DNA in cancer patients' blood.
Methods in molecular biology (Clifton, N.J.) 2009;507():349-56.
2008: Kazuo Koyanagi; Anton J Bilchik; Sukamal Saha; Roderick R Turner; David Wiese; Martin McCarter; Perry Shen; Linda Deacon; David Elashoff; Dave S B Hoon
Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7391-6.
2008: Yasufumi Goto; Takaaki Arigami; Minoru Kitago; Sandy L Nguyen; Norihiko Narita; Soldano Ferrone; Donald L Morton; Reiko F Irie; Dave S B Hoon
Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.
Molecular cancer therapeutics 2008;7(11):3642-53.
2008: Eiji Sunami; Anh-Thu Vu; Sandy L Nguyen; Armando E Giuliano; Dave S B Hoon
Quantification of LINE1 in circulating DNA as a molecular biomarker of breast cancer.
Annals of the New York Academy of Sciences 2008;1137():171-4.
2008: Rooshdiya Z Karim; Richard A Scolyer; Wei Li; Vivian S K Yee; J Gregory McKinnon; Ling-Xi L Li; Roger F Uren; Stella Lam; Alison Beavis; Michael Dawson; Philip Doble; Dave S B Hoon; John F Thompson
False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology.
Annals of surgery 2008;247(6):1003-10.
2008: Yasufumi Goto; Soldano Ferrone; Takaaki Arigami; Minoru Kitago; Atsushi Tanemura; Eiji Sunami; Sandy L Nguyen; Roderick R Turner; Donald L Morton; Dave S B Hoon
Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(11):3401-7.
2008: Michiel F G de Maat; Cornelis J H van de Velde; Martijn P J van der Werff; Hein Putter; Naoyuki Umetani; Elma Meershoek Klein-Kranenbarg; Roderick R Turner; J Han J M van Krieken; Anton Bilchik; R A E M Tollenaar; Dave S B Hoon
Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(14):2327-35.
2008: Emily C Rhodes; Teresa Johnson-Pais; Frederick R Singer; Donna P Ankerst; Jan M Bruder; Julie Wisdom; Dave S B Hoon; Emerald Lin; Henry G Bone; Kenneth J Simcic; Robin J Leach
Sequestosome 1 (SQSTM1) mutations in Paget's disease of bone from the United States.
Calcified tissue international 2008;82(4):271-7.
2008: Farin F Amersi; Alicia M Terando; Yasufumi Goto; Richard A Scolyer; John F Thompson; Andy N Tran; Mark B Faries; Donald L Morton; Dave S B Hoon
Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(3):638-45.
2008: Eiji Sunami; Masaru Shinozaki; Myung-Shin Sim; Sandy L Nguyen; Anh-Thu Vu; Armando E Giuliano; Dave S B Hoon
Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.
Breast cancer research : BCR 2008;10(3):R46.
2007: Atsushi Tanemura; Anneke Q van Hoesel; Takuji Mori; Terrance Yu; Dave S B Hoon
The role of estrogen receptor in melanoma.
Expert opinion on therapeutic targets 2007;11(12):1639-48.
2007: Michiel F G de Maat; Cornelis J H van de Velde; Naoyuki Umetani; Pieter De Heer; Hein Putter; Anneke Q van Hoesel; Gerrit A Meijer; Nicole C van Grieken; Peter Kuppen; Anton J Bilchik; R A E M Tollenaar; Dave S B Hoon
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4887-94.
2007: Anton J Bilchik; Dave S B Hoon; Sukamal Saha; Roderick R Turner; David Wiese; Maggie DiNome; Kazuo Koyanagi; Martin McCarter; Perry Shen; Douglas M Iddings; Steven L Chen; Maria Gonzalez; David Elashoff; Donald L Morton
Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
Annals of surgery 2007;246(4):568-75; discussion 575-7.
2007: Taku Nakagawa; Steve Martinez; Yasufumi Goto; Kazuo Koyanagi; Minoru Kitago; Tatsushi Shingai; David Elashoff; Xing Ye; Frederick R Singer; Armando E Giuliano; Dave S B Hoon
Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4105-10.
2007: Michiel F G de Maat; Naoyuki Umetani; Eiji Sunami; Roderick R Turner; Dave S B Hoon
Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles.
Molecular cancer research : MCR 2007;5(5):461-71.
2007: Tomoki Yamano; Yasufumi Kaneda; Suzanne Hiramatsu; Sharon Huang; A N Tran; Armando E Giuliano; Dave S B Hoon
Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21.
Cancer gene therapy 2007;14(5):451-9.
2007: Hiroya Takeuchi; Nancy C Greep; Dave S B Hoon; Armando E Giuliano; Nora M Hansen; Naoyuki Umetani; Frederick R Singer
Hypermethylation of adenosine triphosphate-binding cassette transporter genes in primary hyperparathyroidism and its effect on sestamibi imaging.
The Journal of clinical endocrinology and metabolism 2007;92(5):1785-90.
2007: Simone Mocellin; Dave S B Hoon; Pierluigi Pilati; Carlo Riccardo Rossi; Donato Nitti
Sentinel lymph node molecular ultrastaging in patients with melanoma: a systematic review and meta-analysis of prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1588-95.
2007: Masaru Shinozaki; Steven J O'Day; Minoru Kitago; Farin Amersi; Christine Kuo; Joseph Kim; He-Jing Wang; Dave S B Hoon
Utility of circulating B-RAF DNA mutation in serum for monitoring melanoma patients receiving biochemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(7):2068-74.
2007: Hiroya Takeuchi; Minoru Kitago; Dave S B Hoon
Effects of chemokines on tumor metastasis.
Cancer treatment and research 2007;135():177-84.
2006: Taku Nakagawa; Sharon K Huang; Steve Martinez; Andy N Tran; David Elashoff; Xing Ye; Roderick R Turner; Armando E Giuliano; Dave S B Hoon
Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis.
Cancer research 2006;66(24):11825-30.
2006: Peter D Boasberg; Dave S B Hoon; Lawrence D Piro; Maureen A Martin; Akhide Fujimoto; Timothy S Kristedja; Sandeep Bhachu; Xing Ye; Regina Deck; Steven J O'Day
Enhanced survival associated with vitiligo expression during maintenance biotherapy for metastatic melanoma.
The Journal of investigative dermatology 2006;126(12):2658-63.
2006: Joseph Kim; Armando E Giuliano; Roderick R Turner; Robyn E Gaffney; Naoyuki Umetani; Minoru Kitago; David Elashoff; Dave S B Hoon
Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.
Annals of surgery 2006;244(5):799-804.
2006: Joseph Kim; Howard A Reber; S M Dry; David Elashoff; Steven L Chen; Naoyuki Umetani; Minoru Kitago; Oscar J Hines; Kevork K Kazanjian; Suzanne Hiramatsu; Anton J Bilchik; Sherri Yong; Margo Shoup; Dave S B Hoon
Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins.
Gut 2006;55(11):1598-605.
2006: Naoyuki Umetani; Armando E Giuliano; Suzanne Hiramatsu; Farin Amersi; Taku Nakagawa; Silvana Martino; Dave S B Hoon
Prediction of breast tumor progression by integrity of free circulating DNA in serum.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4270-6.
2006: Naoyuki Umetani; Suzanne Hiramatsu; Dave S B Hoon
Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation.
Annals of the New York Academy of Sciences 2006;1075():299-307.
2006: Bret Taback; Armando E Giuliano; Ron Lai; Nora Hansen; Frederick R Singer; Klaus Pantel; Dave S B Hoon
Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients.
Annals of the New York Academy of Sciences 2006;1075():211-21.
2006: Bret Taback; Sukamal Saha; Dave S B Hoon
Comparative analysis of mesenteric and peripheral blood circulating tumor DNA in colorectal cancer patients.
Annals of the New York Academy of Sciences 2006;1075():197-203.
2006: Simone Mocellin; Dave S B Hoon; alessandro ambrosi; Donato Nitti; Carlo Riccardo Rossi
The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4605-13.
2006: Takuji Mori; Steve Martinez; Steven J O'Day; Donald L Morton; Naoyuki Umetani; Minoru Kitago; Atsushi Tanemura; Sandy L Nguyen; Andy N Tran; He-Jing Wang; Dave S B Hoon
Estrogen receptor-alpha methylation predicts melanoma progression.
Cancer research 2006;66(13):6692-8.
2006: Joseph Kim; Takuji Mori; Steven L Chen; Farin Amersi; Steve Martinez; Christine Kuo; Roderick R Turner; Xing Ye; Anton J Bilchik; Donald L Morton; Dave S B Hoon
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
Annals of surgery 2006;244(1):113-20.
2006: Kazuo Koyanagi; Takuji Mori; Steven J O'Day; Steve Martinez; He-Jing Wang; Dave S B Hoon
Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients.
Cancer research 2006;66(12):6111-7.
2006: Anton J Bilchik; Maggie DiNome; Sukamal Saha; Roderick R Turner; David Wiese; Martin McCarter; Dave S B Hoon; Donald L Morton
Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
Archives of surgery (Chicago, Ill. : 1960) 2006;141(6):527-33; discussion 533-4.
2006: Dave S B Hoon; Minoru Kitago; Joseph Kim; Takuji Mori; Adriano Piris; Katherine Szyfelbein; Martin C Mihm; S David Nathanson; Timothy P Padera; Ann F Chambers; sharon vantyghem; Ian C MacDonald; Steve Shivers; Marwan Alsarraj; Douglas S Reintgen; Bernward Passlick; Wulf Sienel; Klaus Pantel
Molecular mechanisms of metastasis.
Cancer metastasis reviews 2006;25(2):203-20.
2006: Naoyuki Umetani; Joseph Kim; Suzanne Hiramatsu; Howard A Reber; Oscar J Hines; Anton J Bilchik; Dave S B Hoon
Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats.
Clinical chemistry 2006;52(6):1062-9.
2006: Naoyuki Umetani; Michiel F G de Maat; Eiji Sunami; Suzanne Hiramatsu; Steve Martinez; Dave S B Hoon
Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation.
Molecular cancer research : MCR 2006;4(5):303-9.
2006: Joseph Kim; Howard A Reber; Oscar J Hines; Kevork K Kazanjian; Andy Tran; Xing Ye; Farin Amersi; Steve Martinez; Sarah M Dry; Anton J Bilchik; Dave S B Hoon
The clinical significance of MAGEA3 expression in pancreatic cancer.
International journal of cancer. Journal international du cancer 2006;118(9):2269-75.
2006: Yasufumi Goto; Yuriko Matsuzaki; Sachiko Kurihara; Ayako Shimizu; Tsutomu Okada; Kazuhiko Yamamoto; Hiroshi Murata; Minoru Takata; Hiroyuki Aburatani; Dave S B Hoon; Toshiaki Saida; Yutaka Kawakami
A new melanoma antigen fatty acid-binding protein 7, involved in proliferation and invasion, is a potential target for immunotherapy and molecular target therapy.
Cancer research 2006;66(8):4443-9.
2006: Steve Martinez; Takuji Mori; Dave S B Hoon
Molecular upstaging of sentinel lymph nodes in melanoma: where are we now?
Surgical oncology clinics of North America 2006;15(2):331-40.
2006: Kazuo Koyanagi; Steven J O'Day; Rene Gonzalez; Karl Lewis; William A Robinson; Thomas T Amatruda; Christine Kuo; He-Jing Wang; Robert Milford; Donald L Morton; Dave S B Hoon
Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(4):1137-43.
2006: Tomoki Yamano; Yasufumi Kaneda; Sharon Huang; Suzanne Hiramatsu; Dave S B Hoon
Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
Molecular therapy : the journal of the American Society of Gene Therapy 2006;13(1):194-202.
2005: Takuji Mori; Steven J O'Day; Naoyuki Umetani; Steve Martinez; Minoru Kitago; Kazuo Koyanagi; Christine Kuo; Teh-Ling Takeshima; Robert Milford; He-Jing Wang; Vu D Vu; Sandy L Nguyen; Dave S B Hoon
Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(36):9351-8.
2005: Hiroya Takeuchi; Donald L Morton; David Elashoff; Dave S B Hoon
Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.
International journal of cancer. Journal international du cancer 2005;117(6):1032-8.
2005: Hirozumi Sawai; Yuji Okada; Kevork K Kazanjian; Joseph Kim; Sascha Hasan; Oscar J Hines; Howard A Reber; Dave S B Hoon; Guido Eibl
The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling.
Cancer research 2005;65(24):11536-44.
2005: Hiroya Takeuchi; Joseph Kim; Akihide Fujimoto; Naoyuki Umetani; Takuji Mori; Anton J Bilchik; Roderick Turner; Andy Tran; Christine Kuo; Dave S B Hoon
X-Linked inhibitor of apoptosis protein expression level in colorectal cancer is regulated by hepatocyte growth factor/C-met pathway via Akt signaling.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7621-8.
2005: Kazuo Koyanagi; Steven J O'Day; Rene Gonzalez; Karl Lewis; William A Robinson; Thomas T Amatruda; He-Jing Wang; Robert Elashoff; Hiroya Takeuchi; Naoyuki Umetani; Dave S B Hoon
Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(31):8057-64.
2005: Steve Martinez; Dave S B Hoon
Molecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?
Journal of cellular biochemistry 2005;96(3):473-83.
2005: Naoyuki Umetani; Takuji Mori; Kazuo Koyanagi; Masaru Shinozaki; Joseph Kim; Armando E Giuliano; Dave S B Hoon
Aberrant hypermethylation of ID4 gene promoter region increases risk of lymph node metastasis in T1 breast cancer.
Oncogene 2005;24(29):4721-7.
2005: Kazuo Koyanagi; Christine Kuo; Taku Nakagawa; Takuji Mori; Hideaki Ueno; Arnulfo R Lorico; He-Jing Wang; Eddie Hseuh; Steven J O'Day; Dave S B Hoon
Multimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patients.
Clinical chemistry 2005;51(6):981-8.
2005: Joseph Kim; Hiroya Takeuchi; Stella T Lam; Roderick R Turner; He-Jing Wang; Christine Kuo; Leland J Foshag; Anton J Bilchik; Dave S B Hoon
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2744-53.
2005: Naoyuki Umetani; Michiel F G de Maat; Takuji Mori; Hiroya Takeuchi; Dave S B Hoon
Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase.
Biochemical and biophysical research communications 2005;329(1):219-23.
2005: Masaru Shinozaki; Dave S B Hoon; Armando E Giuliano; Nora M Hansen; He-Jing Wang; Roderick Turner; Bret Taback
Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2156-62.
2005: Takuji Mori; Joseph Kim; Tomoki Yamano; Hiroya Takeuchi; Sharon Huang; Naoyuki Umetani; Kazuo Koyanagi; Dave S B Hoon
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
Cancer research 2005;65(5):1800-7.
2005: Hiroya Takeuchi; Robert A Wascher; Christine Kuo; Roderick R Turner; Dave S B Hoon
Molecular diagnosis of micrometastasis in the sentinel lymph node.
Cancer treatment and research 2005;127():221-52.
2004: Dave S B Hoon
Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?
Nature clinical practice. Oncology 2004;1(2):74-5.
2004: Naoyuki Umetani; Hiroya Takeuchi; Akihide Fujimoto; Masaru Shinozaki; Anton J Bilchik; Dave S B Hoon
Epigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7475-83.
2004: Naoyuki Umetani; Akihide Fujimoto; Hiroya Takeuchi; Masaru Shinozaki; Anton J Bilchik; Dave S B Hoon
Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma.
Oncogene 2004;23(50):8292-300.
2004: Bret Taback; Anton J Bilchik; Sukamal Saha; Takahiro Nakayama; David Wiese; Roderick R Turner; Christine T Kuo; Dave S B Hoon
Peptide nucleic acid clamp PCR: a novel K-ras mutation detection assay for colorectal cancer micrometastases in lymph nodes.
International journal of cancer. Journal international du cancer 2004;111(3):409-14.
2004: Hiroya Takeuchi; Donald L Morton; Christine Kuo; Roderick R Turner; David Elashoff; Robert Elashoff; Bret Taback; Akihide Fujimoto; Dave S B Hoon
Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2671-80.
2004: Akihide Fujimoto; Steven J O'Day; Bret Taback; David Elashoff; Dave S B Hoon
Allelic imbalance on 12q22-23 in serum circulating DNA of melanoma patients predicts disease outcome.
Cancer research 2004;64(12):4085-8.
2004: Bret Taback; Dave S B Hoon
Circulating nucleic acids in plasma and serum: past, present and future.
Current opinion in molecular therapeutics 2004;6(3):273-8.
2004: Lori L Wilson; Linh Tran; Donald L Morton; Dave S B Hoon
Detection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry.
Annals of the New York Academy of Sciences 2004;1022():317-22.
2004: Hiroya Takeuchi; Akihide Fujimoto; Dave S B Hoon
Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients.
Annals of the New York Academy of Sciences 2004;1022():50-4.
2004: Bret Taback; Steven J O'Day; Dave S B Hoon
Quantification of circulating DNA in the plasma and serum of cancer patients.
Annals of the New York Academy of Sciences 2004;1022():17-24.
2004: Bret Taback; Dave S B Hoon
Circulating nucleic acids and proteomics of plasma/serum: clinical utility.
Annals of the New York Academy of Sciences 2004;1022():1-8.
2004: Dave S B Hoon; Mia Spugnardi; Christine Kuo; Sharon K Huang; Donald L Morton; Bret Taback
Profiling epigenetic inactivation of tumor suppressor genes in tumors and plasma from cutaneous melanoma patients.
Oncogene 2004;23(22):4014-22.
2004: Hiroya Takeuchi; Akihide Fujimoto; Maki Tanaka; Tomoki Yamano; Eddy C Hsueh; Dave S B Hoon
CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2351-8.
2004: Akihide Fujimoto; Hiroya Takeuchi; Bret Taback; Eddy C Hsueh; David Elashoff; Donald L Morton; Dave S B Hoon
Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma.
Cancer research 2004;64(6):2245-50.
2004: Hiroya Takeuchi; Bret Taback; Christine Kuo; Dave S B Hoon
Clinicopathological utility of molecular staging for melanoma patients undergoing sentinel lymphadenectomy.
Annals of surgical oncology 2004;11(3 Suppl):152S-5S.
2004: Masaru Shinozaki; Akihide Fujimoto; Donald L Morton; Dave S B Hoon
Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1753-7.
2004: Bret Taback; Steven J O'Day; Peter D Boasberg; Sherry Shu; Patricia Fournier; Robert Elashoff; He-Jing Wang; Dave S B Hoon
Circulating DNA microsatellites: molecular determinants of response to biochemotherapy in patients with metastatic melanoma.
Journal of the National Cancer Institute 2004;96(2):152-6.
2003: Donald L Morton; Dave S B Hoon; Alistair J Cochran; Roderick R Turner; Richard Essner; Hiroya Takeuchi; Leslie A Wanek; Edwin Glass; Leland J Foshag; Eddy C Hsueh; Anton J Bilchik; David Elashoff; Robert Elashoff
Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases.
Annals of surgery 2003;238(4):538-49; discussion 549-50.
2003: Christine T Kuo; Dave S B Hoon; Hiroya Takeuchi; Roderick Turner; He-Jing Wang; Donald L Morton; Bret Taback
Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(19):3566-72.
2003: Robert A Wascher; Donald L Morton; Christine Kuo; Robert Elashoff; He-Jing Wang; Mehri Gerami; Dave S B Hoon
Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(13):2558-63.
2003: Bret Taback; Armando E Giuliano; Nora M Hansen; Frederick R Singer; Sherry Shu; Dave S B Hoon
Detection of tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients.
Cancer research 2003;63(8):1884-7.
2003: Hiroya Takeuchi; Anton J Bilchik; Sukamal Saha; Roderick Turner; David Wiese; Maki Tanaka; Christine Kuo; He-Jing Wang; Dave S B Hoon
c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1480-8.
2003: Robert A Wascher; Kelly T Huynh; Armando E Giuliano; Nora M Hansen; Frederick R Singer; David Elashoff; Dave S B Hoon
Stanniocalcin-1: a novel molecular blood and bone marrow marker for human breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(4):1427-35.
2003: Mia Spugnardi; Stella Tommasi; Reinhard Dammann; Gerd P Pfeifer; Dave S B Hoon
Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Cancer research 2003;63(7):1639-43.
2003: Seiji Yamamoto; Tomoki Yamano; Maki Tanaka; Dave S B Hoon; Sonshin Takao; Ryuichi Morishita; Takashi Aikou; Yasufumi Kaneda
A novel combination of suicide gene therapy and histone deacetylase inhibitor for treatment of malignant melanoma.
Cancer gene therapy 2003;10(3):179-86.
2003: Hiroya Takeuchi; Christine Kuo; Donald L Morton; He-Jing Wang; Dave S B Hoon
Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.
Cancer research 2003;63(2):441-8.
2002: Anton J Bilchik; Dean T Nora; Sukamal Saha; Roderick Turner; David Wiese; Christine Kuo; Xing Ye; Donald L Morton; Dave S B Hoon
The use of molecular profiling of early colorectal cancer to predict micrometastases.
Archives of surgery (Chicago, Ill. : 1960) 2002;137(12):1377-83.
2002: Donald L Morton; Eddy C Hsueh; Richard Essner; Leland J Foshag; Steven J O'Day; Anton J Bilchik; Rishab K Gupta; Dave S B Hoon; Mepur H Ravindranath; J Anne Nizze; Guy Gammon; Leslie A Wanek; He-Jing Wang; Robert Elashoff
Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.
Annals of surgery 2002;236(4):438-48; discussion 448-9.
2002: Bret Taback; Kahoko Hashimoto; Christine T Kuo; Arden Chan; Armando E Giuliano; Dave S B Hoon
Molecular lymphatic mapping of the sentinel lymph node.
The American journal of pathology 2002;161(4):1153-61.
2002: Anton J Bilchik; Dean T Nora; R A E M Tollenaar; Cornelis J H van de Velde; T Wood; Roderick Turner; Donald L Morton; Dave S B Hoon
Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis.
European journal of cancer (Oxford, England : 1990) 2002;38(7):977-85.
2002: Maki Tanaka; Yasufumi Kaneda; Shigeyuki Fujii; Tomoki Yamano; Kahoko Hashimoto; Sharon K S Huang; Dave S B Hoon
Induction of a systemic immune response by a polyvalent melanoma-associated antigen DNA vaccine for prevention and treatment of malignant melanoma.
Molecular therapy : the journal of the American Society of Gene Therapy 2002;5(3):291-9.
2002: Dave S B Hoon; Akihide Fujimoto; Sherry Shu; Bret Taback
Assessment of genetic heterogeneity in tumors using laser capture microdissection.
Methods in enzymology 2002;356():302-9.
2002: Yurika Sugita; Yoshiyuki Fujiwara; Dave S B Hoon; Atsushi Miyamoto; Masato Sakon; Christine T Kuo; Morito Monden
Overexpression of beta 1,4N-acetylgalactosaminyl- transferase mRNA as a molecular marker for various types of cancers.
Oncology 2002;62(2):149-56.
2001: Bret Taback; A D Chan; Christine T Kuo; PJ Bostick; He-Jing Wang; Armando E Giuliano; Dave S B Hoon
Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Cancer research 2001;61(24):8845-50.
2001: Robert A Wascher; PJ Bostick; Kelly T Huynh; R Turner; K Qi; Armando E Giuliano; Dave S B Hoon
Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.
British journal of cancer 2001;85(9):1340-6.
2001: Bret Taback; Armando E Giuliano; Nora M Hansen; Dave S B Hoon
Microsatellite alterations detected in the serum of early stage breast cancer patients.
Annals of the New York Academy of Sciences 2001;945():22-30.
2001: Dave S B Hoon; Christine T Kuo; S Wen; Hong Wang; Leonid S Metelitsa; Charles Patrick Reynolds; Robert C Seeger
Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.
The American journal of pathology 2001;159(2):493-500.
2001: Bret Taback; Y Fujiwara; He-Jing Wang; Leland J Foshag; Donald L Morton; Dave S B Hoon
Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
Cancer research 2001;61(15):5723-6.
2001: T Nakayama; Bret Taback; R Turner; Donald L Morton; Dave S B Hoon
Molecular clonality of in-transit melanoma metastasis.
The American journal of pathology 2001;158(4):1371-8.
2001: I Miyashiro; Christine Kuo; Kelly T Huynh; A Iida; D Morton; Anton J Bilchik; A Giuliano; Dave S B Hoon
Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes.
Clinical chemistry 2001;47(3):505-12.
2001: Anton J Bilchik; Sukamal Saha; David Wiese; J A Stonecypher; Thomas F Wood; S Sostrin; Roderick R Turner; He-Jing Wang; Donald L Morton; Dave S B Hoon
Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(4):1128-36.
2001: Bret Taback; Donald L Morton; Steven J O'Day; D H Nguyen; T Nakayama; Dave S B Hoon
The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2001;158():78-92.
2000: S Fujii; Sharon Huang; T C Fong; D Ando; Francis J Burrows; Douglas J Jolly; John Nemunaitis; Dave S B Hoon
Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients.
Cancer gene therapy 2000;7(9):1220-30.
2000: Dave S B Hoon; PJ Bostick; Christine Kuo; T Okamoto; He-Jing Wang; Robert Elashoff; Donald L Morton
Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.
Cancer research 2000;60(8):2253-7.
2000: T Nakayama; Bret Taback; D H Nguyen; DD Chi; Donald L Morton; Y Fujiwara; Dave S B Hoon
Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients.
Annals of the New York Academy of Sciences 2000;906():87-98.
2000: Anton J Bilchik; M Miyashiro; M Kelley; Christine Kuo; Y Fujiwara; S Nakamori; M Monden; Dave S B Hoon
Molecular detection of metastatic pancreatic carcinoma cells using a multimarker reverse transcriptase-polymerase chain reaction assay.
Cancer 2000;88(5):1037-44.
1999: WZ Zhou; Dave S B Hoon; S K Huang; S Fujii; K Hashimoto; Ryuichi Morishita; Yasufumi Kaneda
RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.
Human gene therapy 1999;10(16):2719-24.
1999: WZ Zhou; Yasufumi Kaneda; S Huang; Ryuichi Morishita; Dave S B Hoon
Protective immunization against melanoma by gp100 DNA-HVJ-liposome vaccine.
Gene therapy 1999;6(10):1768-73.
1999: PJ Bostick; Donald L Morton; Roderick R Turner; Kelly T Huynh; He-Jing Wang; Robert Elashoff; Richard Essner; Dave S B Hoon
Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3238-44.
1999: Y Fujiwara; DD Chi; H Wang; P Keleman; Donald L Morton; R Turner; Dave S B Hoon
Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.
Cancer research 1999;59(7):1567-71.
1998: PJ Bostick; Kelly T Huynh; T Sarantou; Roderick R Turner; K Qi; Armando E Giuliano; Dave S B Hoon
Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR.
International journal of cancer. Journal international du cancer 1998;79(6):645-51.
1998: T Okamoto; R F Irie; S Fujii; S K Huang; A J Nizze; Donald L Morton; Dave S B Hoon
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy.
The Journal of investigative dermatology 1998;111(6):1034-9.
1998: PJ Bostick; S Chatterjee; DD Chi; Kelly T Huynh; Armando E Giuliano; Richard J Cote; Dave S B Hoon
Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2632-40.
1998: Dave S B Hoon; T Okamoto; He-Jing Wang; Robert Elashoff; A J Nizze; Leland J Foshag; Guy Gammon; Donald L Morton
Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1430-7.
1998: Christine T Kuo; PJ Bostick; R F Irie; Donald L Morton; A J Conrad; Dave S B Hoon
Assessment of messenger RNA of beta 1-->4-N-acetylgalactosaminyl-transferase as a molecular marker for metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):411-8.
1998: Richard Essner; C T Kuo; Hong Wang; Duan-Ren Wen; Roderick R Turner; T Nguyen; Dave S B Hoon
Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites.
Cancer 1998;82(2):309-16.
1997: T Okamoto; Y Kaneda; D Yuzuki; S K Huang; DD Chi; Dave S B Hoon
Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine.
Gene therapy 1997;4(9):969-76.